That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...
While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Remote work has soared in popularity since the COVID-19 pandemic. But, a new study suggests the practice has made workers more socially isolated, anxious and depressed compared to people who work ...
California voters can choose any primary candidate, regardless of party, and two candidates from the same party can potentially face off in the general election. By Livia Albeck-Ripka For more than a ...
Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...
Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Recursion outlines runway into early 2028 while maintaining 2026 cash operating expenses under $390M
"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...
At Team '26, the company announces a powerhouse of new AI capabilities built for every corner of modern work Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results